Abstract
Myricetin, one of the most extensively studied polyphenols, is present abundantly in various fruits and vegetables and exhibits diverse pharmacological properties. The multifaceted biological action of myricetin against tumor heterogeneity makes it an impressive anticancer agent whose efficacy has been confirmed by an overwhelming number of studies. Myricetin shows its therapeutic potential by targeting and modulating the expression of various molecular target which are involved in inflammation, cell proliferation, apoptosis, angiogenesis, invasion, and metastasis. Myricetin deters tumor progression by inducing apoptosis via both intrinsic and extrinsic pathway, activating/inactivating several signaling pathways, and reactivating various tumor suppressor genes. This comprehensive review represents the effect of myricetin on various hallmarks of cancer with insight into the molecular mechanism employed by myricetin to mitigate cell proliferation, angiogenesis, metastasis, and induce apoptosis. In addition, enhanced bioavailability of myricetin through conjugation and its increased efficacy as an anticancer agent when used in combination are also highlighted.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alvarez M, Paull K, Monks A, Hose C, Lee JS, Weinstein J, Fojo T (1995) Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute Anticancer Drug Screen. J Clin Investig 95(5):2205–2214. https://doi.org/10.1172/JCI117910
Amararathna M, Johnston MR, Vasantha Rupasinghe HP (2016) Plant polyphenols as chemopreventive agents for lung cancer. Int J Mol Sci 17(8):1. https://doi.org/10.3390/ijms17081352
Barzegar A (2016) Antioxidant activity of polyphenolic myricetin in vitro cell- free and cell-based systems. Mol Biol Res Commun 5(2):87–95
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424. https://doi.org/10.3322/caac.21492
Busch C, Burkard M, Leischner C, Lauer UM, Frank J, Venturelli S (2015) Epigenetic activities of flavonoids in the prevention and treatment of cancer. Clin Epigenet. https://doi.org/10.1186/s13148-015-0095-z
Chen H, Hao J, Wang L, Li Y (2009) Coexpression of invasive markers (uPA, CD44) and multiple drug-resistance proteins (MDR1, MRP2) is correlated with epithelial ovarian cancer progression. Br J Cancer 101(3):432–440. https://doi.org/10.1038/sj.bjc.6605185
Chen H, Lin H, Xie S, Huang B, Qian Y, Chen K, Yang H (2019) Myricetin inhibits NLRP3 inflammasome activation via reduction of ROS- dependent ubiquitination of ASC and promotion of ROS-independent NLRP3 ubiquitination. Toxicol Appl Pharmacol 365:19–29. https://doi.org/10.1016/j.taap.2018.12.019
Ci Y, Zhang Y, Liu Y, Lu S, Cao J, Li H, Han M (2018) Myricetin suppresses breast cancer metastasis through down-regulating the activity of matrix metalloproteinase (MMP)-2/9. Phytother Res 32(7):1373–1381. https://doi.org/10.1002/ptr.6071
Conley-LaComb MK, Saliganan A, Kandagatla P, Chen YQ, Cher ML, Chinni SR (2013) PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling. Molec Cancer 12(1):85
De Santiago DJB (2015) p21-activated kinase1 (Pak1) is a negative regulator of NADPH- oxidase 2 in ventricular myocytes. J Mol Cell Cardiol 715:77–85. https://doi.org/10.1016/j.yjmcc.2013.12.017.p21-activated
Devi KP, Rajavel T, Habtemariam S, Nabavi SF, Nabavi SM (2015) Molecular mechanisms underlying anticancer effects of myricetin. Life Sci 142:19–25. https://doi.org/10.1016/j.lfs.2015.10.004
Di Muzio M, Marinucci A, De Benedictis A, Tartaglini D (2017) A comparative study of data collection methods in the process of nursing: detection of chemotherapy side effects using a self-reporting questionnaire. Acta Clin Croat 56(4):765–772. https://doi.org/10.20471/acc.2017.56.04.26
Dimitrova N, Zamudio JR, Jong RM, Soukup D, Resnick R, Sarma K, Jacks T (2009) CD4+ T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 16(2):91–102. https://doi.org/10.1371/journal.pone.0178059
Erkan M (2013a) The role of pancreatic stellate cells in pancreatic cancer. Pancreatology 13(2):106–109. https://doi.org/10.1016/j.pan.2013.01.008
Erkan M (2013b) Understanding the stroma of pancreatic cancer: co-evolution of the microenvironment with epithelial carcinogenesis. J Pathol 231(1):4–7. https://doi.org/10.1002/path.4213
Franco OE, Shaw AK, Strand DW, Hayward SW (2011) Cancer associated fibroblasts in cancer pathogenesis. Semin Cell Dev Biol 21(1):33–39. https://doi.org/10.1016/j.semcdb.2009.10.010.Cancer
Gilbert ER, Liu D (2010) Flavonoids influence epigenetic-modifying enzyme activity: structure–function relationships and the therapeutic potential for cancer. Curr Med Chem 17:1756–1768
Hassan SM, Khalaf MM, Sadek SA, Abo-Youssef AM (2017) Protective effects of apigenin and myricetin against cisplatin-induced nephrotoxicity in mice. Pharmaceut Biol 55(1):766–774. https://doi.org/10.1080/13880209.2016.1275704
Hong K, Park J, Kim M, Kim H, Lee J, Tuan T, Kim S (2012) Involvement of SIRT1 in hypoxic down-regulation of c-Myc and β -catenin and hypoxic preconditioning effect of polyphenols. Toxicol Appl Pharmacol 259(2):210–218. https://doi.org/10.1016/j.taap.2011.12.025
Huang Y, Matija Snuderl RKJ (2018) Polarization of tumor-associated macrophages: a novel strategy for vascular normalization and anti-tumor immunity. Cancer Cell 19(1):1–2. https://doi.org/10.1038/jid.2014.371
Iyer SC, Gopal A, Halagowder D (2015) Myricetin induces apoptosis by inhibiting P21 activated kinase 1 (PAK1) signaling cascade in hepatocellular carcinoma. Mol Cell Biochem 407(1–2):223–237. https://doi.org/10.1007/s11010-015-2471-6
Janssen LME, Ramsay EE, Logsdon CD, Overwijk WW (2017) The immune system in cancer metastasis: friend or foe? J ImmunoTher Cancer 5(1):1–14. https://doi.org/10.1186/s40425-017-0283-9
Jiao D, Zhang XD (2016) Myricetin suppresses p21-activated kinase 1 in human breast cancer MCF-7 cells through downstream signaling of the β-catenin pathway. Oncol Rep 36(1):342–348. https://doi.org/10.3892/or.2016.4777
Kim ME, Ha TK, Yoon JH, Lee JS (2014) Myricetin induces cell death of human colon cancer cells via BAX/BCL2-dependent pathway. Anticancer Res 34(2):701–706
Kim H, Park S, Choung S (2018) Enhancing effects of myricetin on the osteogenic di ff erentiation of human periodontal ligament stem cells via BMP-2/Smad and ERK/JNK/p38 mitogen-activated protein kinase signaling pathway. Eur J Pharmacol 834(July):84–91. https://doi.org/10.1016/j.ejphar.2018.07.012
Kwun T, Jung I, Eun M, Kwon S, Sik J (2017) Science direct anti-cancer activity of myricetin against human papillary thyroid cancer cells involves mitochondrial dysfunction: mediated apoptosis. Biomed Pharmacother 91:378–384. https://doi.org/10.1016/j.biopha.2017.04.100
Lee HS, Ha AW, Kim WK (2012) Effect of resveratrol on the metastasis of 4T1 mouse breast cancer cells in vitro and in vivo. Nutr Res Pract 6(4):294–300. https://doi.org/10.4162/nrp.2012.6.4.294
Li T, Zhu J, Deng F, Wu W, Zheng Z, Lv C, Qin S (2019) Microarray based functional analysis of myricetin and proteomic study on its anti-inflammatory property. BioMed Res Int 1:1
Ma L, Cao X, Wang H, Lu K, Wang Y, Tu C, Diao A (2019) Discovery of myricetin as a potent inhibitor of human flap endonuclease 1, which potentially can be used as sensitizing agent against HT-29 human colon cancer cells. J Agric Food Chem. https://doi.org/10.1021/acs.jafc.8b05447
Nelson CM, Bissell MJ, Division LS, Berkeley L (2010) Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. Annu Rev Cell Dev Biol 22:287–309. https://doi.org/10.1146/annurev.cellbio.22.010305.104315.Of
Phillips PA, Sangwan V, Borja-Cacho D, Dudeja V, Vickers SM, Saluja AK (2011) Myricetin induces pancreatic cancer cell death via the induction of apoptosis and inhibition of the phosphatidylinositol 3-kinase (PI3K) signaling pathway. Elsevier 308(2):181–188. https://doi.org/10.1016/j.canlet.2011.05.002
Semwal DK, Semwal RB, Combrinck S, Viljoen A (2016) Myricetin: a dietary molecule with diverse biological activities. Nutrients 8(2):1–31. https://doi.org/10.3390/nu8020090
Stoll S (2019) Myricetin inhibits panel of kinases implicated in tumorigenesis. Basic Clin Pharmacol Toxicol 3(January):3–7. https://doi.org/10.1111/bcpt.13201
Sun F, Zheng XY, Ye J, Wu TT, Wang JL, Chen W (2012) Potential anticancer activity of myricetin in human T24 bladder cancer cells both in vitro and in vivo. Nutr Cancer 64(4):599–606. https://doi.org/10.1080/01635581.2012.665564
Sun W, Tao Y, Yu D, Zhao T, Wu L, Yu W, Han W (2018) Myricetin exerts potent anticancer effects on human skin tumor cells. Trop J Pharmaceut Res 17(6):1067–1072. https://doi.org/10.4314/tjpr.v17i6.13
Wang L, Feng J, Chen X, Guo W, Du Y, Wang Y, Zang W (2014) Myricetin enhance chemosensitivity of 5-fluorouracil on esophageal carcinoma in vitro and in vivo. Cancer Cell Int 14(71):1–8. https://doi.org/10.1186/s12935-014-0071-2
Wang G, Wang JJ, Tang XJ, Du L, Li F (2016) In vitro and in vivo evaluation of functionalized chitosan-Pluronic micelles loaded with myricetin on glioblastoma cancer. Nanomed Nanotechnol Biol Med 12(5):1263–1278. https://doi.org/10.1016/j.nano.2016.02.004
Xie J, Zheng Y (2017) Myricetin protects keratinocyte damage induced by UV through IκB/NFκb signaling pathway. J Cosm Dermatol 16(4):444–449. https://doi.org/10.1111/jocd.12399
Xue J, Schmidt SV, Sander J, Draffehn A, Krebs W, Quester I, Schultze JL (2014) Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity 40(2):274–288. https://doi.org/10.1016/j.immuni.2014.01.006
Yao Y, Xie Y, Hong C, Li G, Shen H, Ji G (2014) Development of a myricetin/hydroxypropyl-β-cyclodextrin inclusion complex: preparation, characterization, and evaluation. Carbohyd Polym 110:329–337. https://doi.org/10.1016/j.carbpol.2014.04.006
Yea C, Zhanga C (2018) The natural compound myricetin effectively represses the malignant progression of prostate cancer by inhibiting PIM1 and disrupting the PIM1/CXCR4 interaction. Cell Physiol Biochem 48:1230–1244. https://doi.org/10.1159/000492009
Yi J-L, Shi S, Shen Y-L, Wang L, Chen H-Y, Zhu J, Ding Y (2015) Myricetin and methyl eugenol combination enhances the anticancer activity, cell cycle arrest and apoptosis induction of cis-platin against HeLa cervical cancer cell lines. Int J Clin Exp Pathol 8(2):1116–1127
Zhang C, Zhang G, Liao Y, Gong D (2017) Myricetin inhibits the generation of superoxide anion by reduced form of xanthine oxidase. Food Chem 221:1569–1577. https://doi.org/10.1016/j.foodchem.2016.10.136
Zhang M, Su H, Yan J, Li N, Song Z, Wang H, Huo L (2018) Biomedicine and pharmacotherapy chemopreventive effect of Myricetin, a natural occurring compound, on colonic chronic inflammation and inflammation-driven tumorigenesis in mice. Elsevier 97:1131–1137. https://doi.org/10.1016/j.biopha.2017.11.018
Zheng AW, Chen YQ, Zhao LQ, Feng JG (2017) Myricetin induces apoptosis and enhances chemosensitivity in ovarian cancer cells. Oncol Lett 13(6):4974–4978. https://doi.org/10.3892/ol.2017.6031
Author information
Authors and Affiliations
Contributions
NA: formulation and writing the manuscript, AH and SP: editing the manuscript, MW and KV: collected various research articles for this review.
Corresponding author
Ethics declarations
Conflict of interest
No conflict of interest of the authors is involved with the publication.
Ethical statement
This paper is not been considered in this or any other form for publication elsewhere. No ethics have been violated in compiling this article.
Rights and permissions
About this article
Cite this article
Afroze, N., Pramodh, S., Hussain, A. et al. A review on myricetin as a potential therapeutic candidate for cancer prevention. 3 Biotech 10, 211 (2020). https://doi.org/10.1007/s13205-020-02207-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s13205-020-02207-3